ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2024, Vol 14, No. 4

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Review Article

1. Covid 19-the 21st Century Pandemic: The Novel Coronavirus Outbreak and the Treatment Strategies

Sherin Joseph , Anila Kutty Narayanan*

Adv Pharm Bull. 2022;12(1): 34-44. doi: 10.34172/apb.2022.005

PMCID: PMC9012918 PMID: 35517888 Scopus ID: 85127157166

Article

PDF

Full Text

XML

Cited By:

Editorial

2. Renin Angiotensin System and Covid-19 Infection

Francesco Ferrara* , Antonio Vitiello

Adv Pharm Bull. 2022;12(1): 1-4. doi: 10.34172/apb.2022.001

PMCID: PMC9012934 PMID: 35517880 Scopus ID: 85127162469

Article

PDF

Full Text

XML

Cited By:

Editorial

3. Clinical Pharmacology Aspects in Patients Treated with TNF Inhibitors During SARS-Cov-2 Pandemic

Francesco Ferrara* , Priscilla Santilli, Vilma D'Aiuto, Antonio Vitiello

Adv Pharm Bull. 2021;11(3): 393-394. doi: 10.34172/apb.2021.045

PMCID: PMC8421614 PMID: 34513612 Scopus ID: 85108918350

Article

PDF

Full Text

XML

Cited By:

Editorial

4. Mesenchymal Stem Cells in the Treatment of New Coronavirus Pandemic: A Novel Promising Therapeutic Approach

Sara Razi , Zahra Molavi, Seyed Amir Mirmotalebisohi, Zahra Niknam, Marzieh Sameni, Vahid Niazi, Amirjafar Adibi, Mohsen Yazdani, Mohammad Mehdi Ranjbar, Hakimeh Zali*

Adv Pharm Bull. 2022;12(2): 206-216. doi: 10.34172/apb.2022.023

PMCID: PMC9106958 PMID: 35620342 Scopus ID: 85122964899

Article

PDF

Full Text

XML

Cited By:

Review Article

5. Recent Update of COVID-19 Vaccines

Sameer A. Jadaan* , Abdul Waheed Khan

Adv Pharm Bull. 2022;12(2): 219-236. doi: 10.34172/apb.2022.045

PMCID: PMC9106961 PMID: 35620327 Scopus ID: 85128147762

Article

PDF

Full Text

XML

Cited By:

Mini Review

6. Natural Immunomodulators Treat the Cytokine Storm in SARS-CoV-2

Heba Salah Abbas* , Mona Mohame Abd-elhakeem, Rania Mostafa Abd El Galil, Omar Ahmed Reyad, Heba Ahmed Mohamed, Salma Emad Saber Ismail, Manal Ahmed Nabil

Adv Pharm Bull. 2023;13(1): 79-87. doi: 10.34172/apb.2023.006

PMCID: PMC9871270 PMID: 36721816

Article

PDF

Full Text

XML

Cited By:

Research Article

7. Preparation, Purification and Performance Evaluation of Polyclonal Antibody Against SARS-CoV-2 Produced in Rat

Fatemeh Yaghoobizadeh* , Mohammad Roayaei Ardakani , Mohammad Mehdi Ranjbar , Mohammad Khosravi , Hamid Galehdari

Adv Pharm Bull. 2023;13(3): 563-572. doi: 10.34172/apb.2023.059

PMCID: PMC10460799 PMID: 37646054

Article

PDF

Full Text

XML

Cited By:

Review Article

8. Biosynthesis of Quantum Dots and Their Therapeutic Applications in the Diagnosis and Treatment of Cancer and SARS-CoV-2

Musa Moetasam Zorab , Navid Mohammadjani, Morahem Ashengroph* , Mehran Alavi*

Adv Pharm Bull. 2023;13(3): 411-422. doi: 10.34172/apb.2023.065

PMCID: PMC10460808 PMID: 37646053

Article

PDF

Full Text

XML

Cited By:

Review Article

9. Targeting Viral ORF3a Protein: A New Approach to Mitigate COVID-19 Induced Immune Cell Apoptosis and Associated Respiratory Complications

Minu Treeza M , Sanu Augustine , Aparna Ann Mathew , S.K. Kanthlal* , Rajitha Panonummal*

Adv Pharm Bull. 2023;13(4): 678-687. doi: 10.34172/apb.2023.069

PMCID: PMC10676557 PMID: 38022818

Article

PDF

Full Text

XML

Cited By: